戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  in Patients with Systolic Heart Failure and Mild Symptoms).
2 c T cells in 10 of 10 COVID-19 patients with mild symptoms.
3 fection, with the majority having minimal to mild symptoms.
4 in transplant recipients and associated with mild symptoms.
5 ticipants developed ARIA-E, including 3 with mild symptoms.
6 ere symptoms, but not in patients with no or mild symptoms.
7 sidered a safe and effective option to treat mild symptoms.
8  of a potential immediate drug reaction with mild symptoms.
9 th was endorsed instead of medicalization of mild symptoms.
10 h most patients being asymptomatic or having mild symptoms.
11 tory-confirmed SARS-CoV-2 infection reported mild symptoms.
12 ) positive children were asymptomatic or had mild symptoms.
13 unced when progerin is targeted in mice with mild symptoms.
14 ompleted the study and 11 (5.3%) experienced mild symptoms.
15 ichotomized as moderate to severe or none to mild symptoms.
16  lab-confirmed SARS-CoV-2 infection reported mild symptoms.
17 RT-PCR, although children experienced few or mild symptoms.
18 pping out were low adherence, older age, and mild symptoms.
19 ses COVID-19, most people will develop no or mild symptoms.
20 s are generally asymptomatic or present with mild symptoms.
21 isabled state whereas others experience only mild symptoms.
22 l domain survive for over one year with only mild symptoms.
23  (95%) survived, with 95% experiencing no or mild symptoms.
24 lnut, 83% almond, 73% peanut) reported no or mild symptoms.
25 reactions distinguishing severe allergy from mild symptoms.
26 E at age 4 years compared with children with mild symptoms.
27                Gly m 5 and 6 were related to mild symptoms.
28 lar death in patients with heart failure and mild symptoms.
29  the diagnosis of acute stroke in those with mild symptoms.
30         Eighty percent reported having no or mild symptoms.
31  transthyretin (TTR) Met30 variant, who have mild symptoms.
32 nitial management strategy for patients with mild symptoms.
33 s, and inoculated plants developed only very mild symptoms.
34 r "good" and 86% (43/50) reported "none" or "mild" symptoms.
35  0.16% [95% CI, 0.01%-2.94%]), 232 developed mild symptoms (13.65% [95% CI, 7.76%-22.9%]), and, conve
36  (43.7% and 26.9%) and respondents reporting mild symptoms (29.2% and 24.5%).
37                             Most (88.4%) had mild symptoms; 29.9% had a family member positive for CO
38 ) had severe, 36 (52%) moderate, and 8 (12%) mild symptoms; 38 (37%) received adrenalin.
39 onsillectomy (16 of 25; 64%) groups reported mild symptoms 6 months after surgery.
40                       30.0% (29/96) reported mild symptoms (82.8% [24/29] developed a sore throat); o
41  of individuals with Parkinson disease) have mild symptoms, a good response to dopaminergic medicatio
42                          Patients with no or mild symptoms, a low PVC burden, and normal ventricular
43 nfected individuals are asymptomatic or show mild symptoms, a risk of neurologic complications is ass
44 ed challenges without reaction, 4 (4.2%) had mild symptoms after 25 mg, and 4 (4.2%) after 250-mg dos
45 ion is suggested to be associated with no or mild symptoms among peanut-sensitized subjects.
46   Among the 767 randomized patients, 539 had mild symptoms and 228 patients had moderate to severe HD
47 cal evaluation, 192 patients (69%) had no or mild symptoms and 69 (25%) experienced incapacitating sy
48 s 2 (SARS-CoV-2) are more likely to manifest mild symptoms and are at a lower risk of developing seve
49  host defense in the lung is associated with mild symptoms and disease resolution.
50  involves a solitary enlarged lymph node and mild symptoms and excision surgery is often curative.
51 ome corneal dystrophies may result in few or mild symptoms and morbidity throughout a patient's lifet
52 confirmation of infection by SARS-CoV-2) had mild symptoms and most did not require admission or inva
53 of schizophrenia of 18 years with minimal to mild symptoms and nearly one-fifth loss of functioning,
54 ) experienced SARS-CoV-2 infection, all with mild symptoms and no hospitalizations.
55 gG-positive survivors, including one who had mild symptoms and one who was asymptomatic, resulting in
56 el did not differ between patients with none/mild symptoms and patients with moderate/severe symptoms
57 rophy), severe symptoms (OR 3.4 (1.8-6.7) vs mild symptoms) and vomiting (OR 3.1 (1.5-6.3).
58 as having no symptoms, 282 (33.7%) as having mild symptoms, and 31 (3.7%) as having severe symptoms.
59 ents who died suddenly, most (71%) had no or mild symptoms, and 7 (16%) participated in moderate to s
60 scores of 0 to 4 were categorized as none to mild symptoms, and scores of 5 to 10 were categorized as
61 ns were asymptomatic or were associated with mild symptoms, and there was no intra- facility spread r
62  or replacement) should take place when even mild symptoms appear or when ejection fraction approache
63 y of individuals exposed to JEV only develop mild symptoms associated with long-lasting adaptive immu
64  effect of A243V is consistent with the more mild symptoms associated with this mutation.
65 patients (44%), and 16 of 34 (47%) still had mild symptoms at 2 years or more after surgery.
66  COVID-19 hospitalization than those with no/mild symptoms at 6 months post-infection.
67 nd Zika virus (ZIKV) usually present similar mild symptoms at early stages, and most infections (~80%
68 o 80 years) with 91% experiencing no or only mild symptoms at last evaluation.
69 of the case, including the patient's initial mild symptoms at presentation with progression to pneumo
70 dal symptom assessments indicating normal to mild symptoms at screening.
71 500 parasites per 200 white cells) with only mild symptoms before severe malaria, after severe malari
72 ent PTSD were more likely to report at least mild symptom burden (57% vs 36%), mild physical limitati
73 thout depressive symptoms to report at least mild symptom burden (60% vs 33%; P<.001), mild physical
74 ad no symptoms, with the remaining 8% having mild symptoms but requiring no treatment.
75              Mumps is mainly associated with mild symptoms, but severe complications such as encephal
76 oV-2) are predominantly asymptomatic or have mild symptoms compared with the more severe coronavirus
77 Seventeen of 22 assessable children, who had mild symptoms comprised of paresis alone, fully recovere
78 rs, and her affected mother only experienced mild symptoms during adolescence, which disappeared at t
79 ction from lethal outcomes and manifest only mild symptoms during infection.
80  In patients with systolic heart failure and mild symptoms, eplerenone reduced the incidence of new o
81                                          The mild symptoms exhibited by strains infected with CHV-1/E
82 Although young children generally experience mild symptoms following infection with SARS-CoV-2, sever
83 oos grade III and IV VS without or with only mild symptoms from brainstem compression, SRS can be rec
84 or a substantial proportion of patients with mild symptoms, general management principles, including
85                                              Mild symptoms generally started within 1 day of peak vir
86                              Volunteers with mild symptoms had a prevalence of disk displacement of t
87        Respondents reporting very severe (vs mild) symptoms had 2.25 times higher prevalence of 30-da
88 ly ill COVID-19 patients, but not those with mild symptoms, had high concentrations of afucosylated I
89 y, however, COVID-19 patients who experience mild symptoms have a higher viral load than those with s
90              HAdV infections typically cause mild symptoms; however, individuals such as children, th
91  virus (ZIKV) infection typically results in mild symptoms; however, it can cause elevated inflammati
92  any psychiatric disorder, and may show only mild symptoms, if any.
93 ere symptoms in 5 of 31 patients (16.1%) and mild symptoms in 11 of 282 (3.9%) compared with no sympt
94 d some strains have been shown to cause only mild symptoms in experimental infections.
95 a virus (LASV) infection, typically leads to mild symptoms in humans, but some survivors experience a
96 ted fatality rate of 29.7%, but causes no or mild symptoms in many individuals.
97                       COVID-19 presents with mild symptoms in the majority of patients but in a minor
98 nge, 61-96 years), most (n=245, 88%) with no/mild symptoms, including 135 with >/=1 conventional sudd
99                       For most patients with mild symptoms, lifestyle changes, dietary adjustments, a
100                               Malaria causes mild symptoms like fever, headache, sweating and vomitin
101       Although most PARADIGM-HF patients had mild symptoms, many were at high risk for adverse outcom
102  Nonessential allergy diets in children with mild symptoms may harm the development of immunological
103 ] age, 46.1 [14.7] years) than patients with mild symptoms (mean [SD] age, 41.3 [12.5] years) and tho
104     In this large HCM cohort with no or only mild symptoms, myocardial fibrosis detected by CMR was a
105                                              Mild symptoms (n = 118) were defined as New York Heart A
106 n hospital personnel (n = 24), who developed mild symptoms necessitating leave of absence and self-is
107 ade symptom; or (3) CoFAR v3 with at least 2 mild symptoms occurring in different organ systems.
108 conservative interpretation of CoFAR v3 (>=2 mild symptoms occurring in different systems) resulted i
109                                              Mild symptoms of acute retroviral syndrome occurred in t
110 sociated with sex, body mass index, smoking, mild symptoms of airway infection, and chronic asthma an
111      Aged Il7ralpha-DeltaTreg mice displayed mild symptoms of autoimmunity correlating with impaired
112 cclusive disease is most often manifested by mild symptoms of claudication that can be managed conser
113 ho contracted SARS-CoV-2, yet developed only mild symptoms of COVID-19.
114  healthcare workers to provide treatment for mild symptoms of depression and anxiety.
115                                         Even mild symptoms of depression during the treatment-plannin
116  of a large proportion of patients with only mild symptoms of HDM-induced rhino-conjunctivitis.
117  events versus placebo in 2737 patients with mild symptoms of heart failure and an ejection fraction
118                      All eight patients have mild symptoms of HPS; two Jewish patients had received t
119 uccessful second HSCT, the patient developed mild symptoms of lipodystrophy, which raised the suspici
120               Conclusions and Relevance: For mild symptoms of nausea and emesis of pregnancy, ginger,
121                                The typically mild symptoms of PFS can lead to an erroneous perception
122 ght be the inclusion of mainly patients with mild symptoms of rhino conjunctivitis (539 of in total 7
123 rine fetal demise in unvaccinated women with mild symptoms of SARS-CoV-2 Delta variant infection.
124              Whereas some patients have only mild symptoms of short duration, others develop severe d
125  acceptable safety profile) in patients with mild symptoms of systolic heart failure, even in those a
126            Most children had only one or two mild symptoms of URI, which were not associated with the
127 up to 80% of infected individuals experience mild symptoms or are asymptomatic, confounding efforts t
128 infected individuals, who can either exhibit mild symptoms or progress toward a life-threatening acut
129 care workers who were symptomatic (including mild symptoms) or had known infection exposure.
130 antly more likely than those with limited or mild symptoms, or non-exposed controls to have APA (p <
131  6 was significantly higher in patients with mild symptoms (P = 0.04, 0.02 and 0.02, respectively).
132      This analysis explores whether oHCM and mild symptoms patients experience similar clinical benef
133 amin B6, antihistamines, metoclopramide (for mild symptoms), pyridoxine-doxylamine, and ondansetron (
134 fe for patients who are asymptomatic or have mild symptoms, reassuring thoracic imaging, and a histor
135 h SARS-CoV-2 (Omicron variant) infection and mild symptoms received molnupiravir in an outpatient bas
136                                              Mild symptoms recur in one fifth.
137  mitral regurgitation in patients with no or mild symptoms remains controversial, particularly becaus
138 s with limited symptoms, two (8%) of 26 with mild symptoms, seven (44%) of 16 with moderate symptoms,
139  MP-AzeFlu children achieved symptom-free or mild symptom severity status, and did so up to 16 days f
140                                              Mild symptom severity was marked by upregulation of clas
141 stic criteria progress slowly and plateau at mild symptom severity.
142 undiagnosed; infected individuals, even with mild symptoms, shed HSV, and can infect sexual partners.
143 anifestations in SC intoxication ranges from mild symptoms, such as abdominal pain and vomiting, to e
144 w threshold for CT scanning of patients with mild symptoms that are suggestive of SAH may reduce the
145 ostic criteria include syndromes with few or mild symptoms that are suggestive of underlying PSP path
146         Humans can also become infected with mild symptoms that can progress to more severe symptoms,
147 irus 2 (SARS-CoV-2) infection typically have mild symptoms that do not require medical attention, lea
148 ren with SARS-CoV-2 infection typically have mild symptoms that do not require medical attention, lea
149 a varied clinical course; some patients have mild symptoms that necessitate little or no therapy, whe
150               While cases often present with mild symptoms, the risk of invasive disease shortly afte
151 f endovascular thrombectomy in patients with mild symptoms, the use of intravenous thrombolysis in an
152 ty and Morbidity in Heart Failure) trial had mild symptoms, there is a poor correlation between repor
153 lizations in patients with heart failure and mild symptoms to a greater extent than is captured by on
154                     Their effects range from mild symptoms to catastrophes in which large areas plant
155 elop neurological complications ranging from mild symptoms to dementia.
156  heterogeneous clinical course, ranging from mild symptoms to life-threatening complications.
157     Their clinical manifestation ranges from mild symptoms to life-threatening episodes.
158                The disease burden spans from mild symptoms to profound disability, the scale making t
159 al ZIKV infection while it brings about only mild symptoms to the health-competent older children or
160 ectrum of clinically apparent syndromes from mild symptoms to tissue-invasive, resulting in both dire
161                       Patients with oHCM and mild symptoms treated with aficamten achieved significan
162 Parkinson disease, in certain instances (eg, mild symptoms, tremor as the only or most prominent symp
163          Patients with a clinical variant or mild symptoms were also included.
164  subjects still dosing during years 3 and 4, mild symptoms were present in 12 (54.5%) of 22 subjects.
165              Affected gilts displayed non-to-mild symptoms, whereas gestational sows experienced repr
166 ariable with the majority of patients having mild symptoms while others develop severe respiratory fa
167 ccinated and boosted returning traveler with mild symptoms who was identified through community surve
168 e asymptomatic and 21 LTRs (67.8%) were with mild symptoms with a mean duration of 4.6 d (interquarti
169 nd confirmed experiencing no symptoms or few mild symptoms with limited personal impact (n = 2426).
170 tious and aim for clinical remission or only mild symptoms with near-normal function and quality of l
171 via intrabronchial instillation demonstrated mild symptoms, with disease severity depending on the in
172 st of the patients were asymptomatic or with mild symptoms, without any major analytical alterations,
173 tracting Zika virus (ZIKV) typically exhibit mild symptoms, yet ZIKV infection of pregnant individual

 
Page Top